Phase 3 Trial

Novartis' Lung Cancer Candidate Misses Primary Goal In Post Surgery Setting

BELLUS Health Announces FDA End-of-Phase 2 Meeting For Refractory Chronic Cough Program

Pfizer's Ulcerative Colitis Candidate Shows Remission In Over 30% Of Patients In Pivotal Studies

BELLUS Health Announces FDA End-of-Phase 2 Meeting For Refractory Chronic Cough Program

Pfizer's Ulcerative Colitis Candidate Shows Remission In Over 30% Of Patients In Pivotal Studies

Novartis - BeiGene's Tislelizumab Aces Late-Stage Esophageal Cancer Trial

Ampio Pharma Shares Fall As FDA Rejects Proposed Change In Knee Osteoarthritis Trial

Novartis - BeiGene's Tislelizumab Aces Late-Stage Esophageal Cancer Trial

Ampio Pharma Shares Fall As FDA Rejects Proposed Change In Knee Osteoarthritis Trial

BeiGene Shares Updated Data From Tislelizumab Combo Trial In Head & Neck Cancer

Aeglea Bio Stock Gains On Additional Pegzilarginase Data For Rare Metabolic Disease

Phase 3 Trial Recent News

Bristol Myers' Neoadjuvant Opdivo/Chemo Therapy Yet To Reach Overall Survival Endpoint In Early-Stage Lung Cancer

Bristol Myers Squibb Co (NYSE: BMY) announced results from the Phase 3 CheckMate -816 trial in resectable non-small cell lung cancer (NSCLC).

Eli Lilly Reveals More Phase 3 Data From Lebrikizumab Trial In Atopic Dermatitis

Eli Lilly And Co (NYSE: LLY)

Veru's Stock Nearly Triples As COVID-19 Drugs Cuts Reduces Deaths By 55% In Hospitalized Patients

Veru Inc (NASDAQ: VERU) has

Tonix Pharma Starts New Pivotal Trial For TNX-102 SL In Fibromyalgia Patients

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) has

Vaxxinity Receives $9.25M Funding From CEPI To Support Pivotal COVID-19 Vaccine Trial

Biophytis Shares Fall As It Stops Enrollment In Sarconeos COVID-19 Trial, Data Expected In Q3 2022

Citius Pharma Reveals Topline Immunotherapy Data From Late-Stage Lymphoma Trial

AstraZeneca's Ultomiris Shows Sustained Improvements In Functional Activities In Neuromuscular Disease

Novartis Highlights Four-Year Efficacy, Safety Data On Kesimpta In Multiple Sclerosis

Theravance Biopharma's Ampreloxetine Shows Benefit In Atrophy Patients, But Not In Parkinson's

Theravance Biopharma Inc (NASDAQ: TBPH)

Argenx's Vyvgart Long-Term Treatment Shows Improved gMG Disease Scores

Argenx SE (NASDAQ: ARGX) announced

Lexicon Touts New Favorable Data On Sotaglifozin Cardio Data

Merck - Ridgeback's COVID-19 Antiviral Shows Rapid Elimination Of Infectious SARS-CoV-2 Than Placebo

Merck & Co Inc (NYSE: MRK) and Ridgeback Biotherapeutics will present data evaluating Lagevrio (molnupiravir), an oral COVID-19 antiviral, at the 2022 European Congress of Clinical Microbiology & Infectious Diseases.

Sorrento To Start Late-Stage Trial Of Abivertinib In Critically-Ill COVID-19 Patients

InflaRx Shares Plunge After Disappointing Results On Vilobelimab In Critically Ill COVID-19 Patients

Roche's Tiragolumab Immunotherapy Flunks In Late-Stage Lung Cancer Trial

Roche Holding AG's (OTC: RHHBY) Phase 3 SKYSCRAPER-02 study in extensive-stage small-cell lung cancer (ES-SCLC)

Incyte-Lilly's Olumiant Continue To Show Improved Scalp, Eyebrows, Eyelash Hair Regrowth At 52 Weeks

At the American Academy of Dermatology Annual Meeting, Eli Lilly And Co (NYSE: LLY) and Incyte Corp (NASDAQ: INCY)

Roivant' Dermavant Showcases New Long-Term Durability, Tolerability Data For Plaque Psoriasis Candidate

Roivant Sciences Ltd's (NASDAQ: ROIV) subsidiary Dermavant Sciences announced results from Phase 3 PSOARING 3 long-term extension study of tapinarof cream 1% for plaque psoriasis in adults.

Celcuity Plans To Start Pivotal Gedatolisib Trial In Breast Cancer In 1H 2022

AstraZeneca's Imfinzi Flunks In Late-Stage Advanced Cervical Cancer Study

Pfizer's Ulcerative Colitis Candidate Aces Late-Stage Study

ObsEva Unveils Additional Efficacy Results for Linzagolix In Endometriosis-Associated Pain

Tonix Says Fibromyalgia Candidate Failed To Achieve Statistical Significance Over Placebo

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) says that as expected, TNX-102 SL (cyclobenzaprine HCl sublingual tablets)